Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tradr 2X Short TSLA Daily ETF
TSLQ
5
Short S&P 500 Proshares
SH
US Stock MarketDetailed Quotes
DNLI Denali Therapeutics
- 14.320
- +0.350+2.51%
Close May 7 16:00 ET
- 14.470
- +0.150+1.05%
Pre 05:22 ET
2.08BMarket Cap-5.36P/E (TTM)
14.420High13.355Low1.84MVolume13.950Open13.970Pre Close25.91MTurnover1.41%Turnover RatioLossP/E (Static)145.28MShares33.33052wk High1.85P/B1.87BFloat Cap10.57052wk Low--Dividend TTM130.90MShs Float93.940Historical High--Div YieldTTM7.62%Amplitude10.570Historical Low14.068Avg Price1Lot Size
Denali Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -15.71%-131.47M | 2.88%-347.69M | 15.15%-83.72M | 32.31%-59.14M | 19.39%-91.22M | -93.22%-113.62M | -46.29%-357.99M | -35.77%-98.66M | -53.14%-87.36M | -163.81%-113.17M |
| Net income from continuing operations | -30.62%-132.97M | -191.12%-422.77M | 3.95%-114.75M | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.45%-145.22M | -21.07%-119.47M | 3.82%-99.35M | 411.91%183.38M |
| Operating gains losses | ---- | ---14.54M | --0 | --0 | --0 | ---14.54M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 48.57%3.21M | -46.24%8.99M | 20.30%2.62M | 2.35%2.27M | -15.01%1.94M | -78.48%2.16M | 61.09%16.73M | -46.79%2.18M | 3.55%2.22M | 10.28%2.29M |
| Other non cash items | -9.61%-1.05M | -9.60%-4.07M | -9.84%-1.05M | -9.61%-1.05M | -9.81%-1.02M | -9.12%-957K | -13.05%-3.72M | -12.22%-955K | -16.85%-957K | -11.14%-928K |
| Change In working capital | -38.73%-21.93M | 105.84%16.94M | 80.46%10.56M | 788.70%30.35M | 97.39%-8.16M | -173.27%-15.81M | -1,106.52%-289.93M | 792.98%5.85M | -120.95%-4.41M | -3,103.79%-312.95M |
| -Change in prepaid assets | -52.44%-28.61M | 39.42%-2.48M | 102.42%145K | 20,257.47%17.71M | -143.47%-1.57M | -948.97%-18.77M | -48.33%-4.09M | -336.97%-6M | -99.35%87K | 122.58%3.61M |
| -Change in payables and accrued expense | -408.39%-9.12M | 270.43%18.81M | 2.79%12.57M | 406.08%9.87M | 75.98%-6.59M | -87.43%2.96M | -61.50%5.08M | 429.07%12.23M | -128.72%-3.23M | -509.23%-27.44M |
| -Change in other current assets | ---943K | --603K | --1.78M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in other current liabilities | ---- | --0 | ---- | ---- | ---- | ---- | ---379K | ---- | ---- | ---- |
| -Change in other working capital | --16.73M | ---- | ---- | ---- | ---- | ---- | -743.05%-290.53M | --0 | 64.37%-1.27M | -60,259.71%-289.12M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -15.71%-131.47M | 2.88%-347.69M | 15.15%-83.72M | 32.31%-59.14M | 19.39%-91.22M | -93.22%-113.62M | -46.29%-357.99M | -35.77%-98.66M | -53.14%-87.36M | -163.81%-113.17M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 104.14%18.75M | -135.60%-88.76M | 135.75%172.21M | -7.19%93.66M | -41.35%98.57M | -388.80%-453.19M | 276.33%249.31M | 157.27%73.05M | 554.45%100.91M | 89.63%168.07M |
| Net PPE purchase and sale | -136.19%-5.08M | -22.98%-15.91M | -127.83%-5.09M | -87.81%-3.88M | 18.19%-4.79M | 22.83%-2.15M | 27.44%-12.94M | 53.91%-2.24M | 65.82%-2.07M | -102.21%-5.85M |
| Net investment purchase and sale | 105.28%23.83M | -127.78%-72.84M | 135.51%177.3M | -5.28%97.54M | -40.57%103.36M | -401.55%-451.04M | 312.25%262.25M | 161.35%75.28M | 379.65%102.98M | 90.02%173.92M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 104.14%18.75M | -135.60%-88.76M | 135.75%172.21M | -7.19%93.66M | -41.35%98.57M | -388.80%-453.19M | 276.33%249.31M | 157.27%73.05M | 554.45%100.91M | 89.63%168.07M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.75%-3.76M | 2,617.76%484.3M | -188.59%-4.17M | -844.74%-18.56M | -25.09%6.76M | 31,089.21%500.28M | -94.26%17.82M | -98.43%4.71M | -51.65%2.49M | 104.88%9.02M |
| Net issuance payments of debt | ---4.36M | ---32.34M | ---8.32M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | --0 | --499.25M | --0 | --0 | --0 | --499.25M | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | -41.78%595K | -2.42%17.39M | -11.69%4.16M | 118.94%5.46M | -25.09%6.76M | -36.28%1.02M | 23.28%17.82M | 36.93%4.71M | -51.65%2.49M | 104.88%9.02M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -100.75%-3.76M | 2,617.76%484.3M | -188.59%-4.17M | -844.74%-18.56M | -25.09%6.76M | 31,089.21%500.28M | -94.26%17.82M | -98.43%4.71M | -51.65%2.49M | 104.88%9.02M |
| Net cash flow | ||||||||||
| Beginning cash position | 37.19%176.54M | -41.39%128.68M | -38.36%92.21M | -42.90%76.25M | -10.75%62.15M | -41.39%128.68M | -25.57%219.54M | 24.54%149.59M | -14.71%133.55M | -34.59%69.63M |
| Current changes in cash | -75.08%-116.48M | 152.67%47.85M | 503.37%84.32M | -0.51%15.96M | -77.93%14.11M | 55.62%-66.53M | -20.46%-90.86M | -121.03%-20.91M | 143.97%16.04M | 27.49%63.92M |
| End cash Position | -3.37%60.05M | 37.19%176.54M | 37.19%176.54M | -38.36%92.21M | -42.90%76.25M | -10.75%62.15M | -41.39%128.68M | -41.39%128.68M | 24.54%149.59M | -14.71%133.55M |
| Free cash flow | -17.95%-136.55M | 1.97%-363.61M | 11.98%-88.81M | 29.53%-63.02M | 19.34%-96.01M | -87.97%-115.77M | -41.28%-370.93M | -30.16%-100.89M | -41.74%-89.43M | -159.92%-119.02M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now